Probiotics and antibiotics: why combine them and how to use them correctly?

The combination of probiotics and antibiotics is garnering increasing interest, both among healthcare professionals and consumers keen to protect their gut microbiota. While antibiotics represent a major advance in modern medicine and remain indispensable in many situations, their action does not solely target the bacteria responsible for infection. They also influence the gut flora, sometimes creating a temporary intestinal imbalance.

In this context, understanding the complementarity between probiotics and antibiotics becomes essential. Live microorganisms, also known as lactic ferments or specific bacterial strains, can contribute to microbiota balance during an antibiotic regimen. This approach is part of a holistic vision of digestive health, consistent with Biocyte's nutricosmetic expertise. Biocyte is the leading French laboratory specializing at the interface of nutrition and cosmetics, recognized for the scientific quality of its formulations.

The combination of probiotics and antibiotics is part of a complementary approach aimed at preserving the balance of the gut microbiota throughout an antibiotic regimen, taking into account the complex interactions between anti-infective treatment and the digestive ecosystem.

The gut microbiota is a complex ecosystem composed of billions of microorganisms. This dynamic ensemble plays a key role in digestion, nutrient metabolism, and the proper functioning of the immune system. When antibiotic treatment is initiated, its objective is to eliminate pathogenic bacteria responsible for the infection. However, its action can also affect commensal bacteria useful for the balance of the gut flora.

Several clinical studies have shown that an antibiotic regimen can temporarily reduce bacterial diversity and alter the composition of the microbiota. This alteration, sometimes referred to as dysbiosis, corresponds to a loss of balance between beneficial bacteria and opportunistic bacteria. Depending on the molecule used and the duration of treatment, this disturbance can be more or less pronounced.

In this context, the combination of probiotics and antibiotics aims to support this weakened ecosystem. Selected microorganisms can contribute to maintaining a more stable intestinal environment, especially when bacterial diversity is temporarily reduced.

The intestinal imbalance induced by antibiotic therapy can manifest as various discomforts. Antibiotic-associated diarrhea is one of the most frequently observed effects. It results in part from changes in the bacterial flora, which alters the fermentation of food substrates and the regulation of transit.

Bloating, abdominal pain, or a feeling of difficult digestion can also appear. These manifestations often reflect temporary dysbiosis. In some people, the reduction of protective bacteria can also promote the proliferation of opportunistic microorganisms, notably responsible for mycoses.

The combination of probiotics and antibiotics is therefore part of an approach to support digestive comfort. It is not about replacing the antibiotic, which is essential in managing the infection, but about supporting the body during this period of vulnerability.

Probiotics, defined as living microorganisms which, when administered in adequate amounts, confer a health benefit on the host, can contribute to the balance of the gut flora. In the context of a probiotics and antibiotics duo, they help maintain a more stable intestinal environment.

Their mechanism of action is based on several axes. Some strains temporarily occupy the ecological space left free by the reduction of commensal bacteria. Others interact with the intestinal mucosa and contribute to the modulation of the local immune system. Finally, some participate in the production of beneficial metabolites from fermentation.

In an expert nutricosmetic approach, the quality of a food supplement is based on the precise identification of strains, their resistance to gastric acidity, and a guaranteed number of Colony Forming Units (CFU) at the expiration date. These technical criteria are crucial for optimizing the complementarity of probiotics and antibiotics.

The choice of microorganisms is crucial in a probiotic and antibiotic strategy, as not all strains have the same level of scientific validation or the same functional properties during antibiotic therapy.

Not all strains have the same properties. In the probiotic and antibiotic context, some have been the subject of specific clinical studies. Saccharomyces boulardii, a probiotic yeast, is recognized for its natural resistance to the action of antibiotics. Its eukaryotic structure allows it not to be affected by antibacterial molecules.

Lactobacillus rhamnosus GG is also widely documented. Randomized controlled trials have evaluated its interest in supporting transit during antibiotic therapy, particularly in children and adults. The complete identification of the strain, including the precise denomination, is a guarantee of scientific rigor.

Thus, in a probiotics and antibiotics strategy, prioritizing clearly identified and clinically validated strains reinforces the coherence of the protocol.

The question of choosing between multi-strain probiotics and mono-strain probiotics arises frequently. Multi-strain formulas combine several complementary microorganisms, likely to act on different physiological mechanisms.

In the context of a probiotic and antibiotic duo, a multi-strain formula can offer interesting functional diversity. It may include strains of Lactobacillus, Bifidobacterium, and sometimes yeasts such as Saccharomyces boulardii. This diversity can contribute to a more global approach to intestinal imbalance.

However, relevance depends on the individual context, the type of antibiotic, and digestive sensitivity. The essential remains the technological quality, the stability of the strains, and the number of CFUs guaranteed at expiration.

Diarrhea is one of the most studied situations related to the combination of probiotics and antibiotics. Several meta-analyses have highlighted the benefit of certain strains to support transit during antibiotic therapy.

Saccharomyces boulardii and Lactobacillus rhamnosus GG are among the most documented. Their action seems linked to the modulation of the intestinal barrier and competition with opportunistic microorganisms.

It is important to note that these supplements do not replace medical advice. In case of persistent or severe symptoms, consultation is necessary.

The effectiveness of a probiotic and antibiotic combination relies not only on the choice of strains but also on appropriate administration methods to optimize their viability and interaction with the gut microbiota.

In a probiotic and antibiotic strategy, timing is crucial. It is generally advised to space out probiotic intake from antibiotic intake by two to three hours. This precaution limits the direct exposure of bacterial strains to the antibacterial molecule.

This arrangement helps optimize the viability of ingested microorganisms. Formulations resistant to gastric acidity or micro-encapsulated can also improve their survival to the intestine.

The complementarity of probiotics and antibiotics does not stop with the last antibiotic pill. The post-treatment period is often when the gut microbiota remains most vulnerable. It is recommended to continue taking probiotic supplements for 7 to 14 days after the end of treatment. This duration helps support the rebalancing dynamic of the gut flora.

Dosage is expressed in CFU, or Colony Forming Units. In the context of probiotics and antibiotics, dosages ranging from a few billion to several tens of billions of CFUs per day are frequently used in studies. The guarantee of the number of CFUs at the expiry date is a major quality criterion. This technical requirement reflects the seriousness of the formulation and aligns with the scientific approach promoted by Biocyte.

Probiotic supplements come in different forms. Gastro-resistant capsules protect the strains from gastric acidity. Liquid forms or sachets are sometimes suitable for specific populations.

The choice of form contributes to adherence to the probiotic and antibiotic protocol, an essential condition for its functional effectiveness.

The combination of probiotics and antibiotics can help maintain digestive comfort, modulate the intestinal immune system, and promote a more gradual recovery of bacterial diversity.

Clinical studies have shown a reduction in the incidence of diarrhea in subjects receiving certain specific strains. Other work suggests participation in the overall balance of the gut microbiota after treatment.

The time needed for the intestinal microbiota to rebalance varies depending on the type of antibiotic, the duration of treatment, age, and diet. Some studies indicate a gradual return to a composition close to the initial state within a few weeks, while others show that some species may take longer to re-establish themselves.

During this phase, the combination of probiotics and antibiotics, extended after treatment, can help support this natural dynamic.

• Hempel S. et al., Probiotics for the prevention and treatment of antibiotic-associated diarrhea: JAMA, 2012.
• McFarland L.V., Systematic review and meta-analysis of Saccharomyces boulardii in adult patients, World J Gastroenterol, 2010.
• Szajewska H. et al., Lactobacillus rhamnosus GG for preventing antibiotic-associated diarrhea in children, Aliment Pharmacol Ther, 2009.
• Langdon A. et al., The effects of antibiotics on the microbiome, Genome Medicine, 2016.
• Suez J. et al., Post-antibiotic gut mucosal microbiome reconstitution, Cell, 2018.